Autor: |
Howard JL, Pollard GT, Craft RM, Rohrbach KW |
Jazyk: |
angličtina |
Zdroj: |
Pharmacology, biochemistry, and behavior [Pharmacol Biochem Behav] 1987 May; Vol. 27 (1), pp. 165-9. |
DOI: |
10.1016/0091-3057(87)90491-6 |
Abstrakt: |
The substituted benzamide metoclopramide has been reported to block the behavioral effects of dopamine agonists, whereas its congener sulpiride potentiates these effects. We injected metoclopramide 2.0, 4.0, or 8.0 mg/kg PO into rats 2 hr before d-amphetamine 1.5 mg/kg IP and measured locomotion for 3 hr. We injected metoclopramide 8.0 mg/kg PO into rats 2 hr before d-amphetamine 1.5, 3.0, or 6.0 mg/kg IP and measured stereotypy for 3 hr. Metoclopramide potentiated the effects of all doses of d-amphetamine on both measures; peak effects occurred in the second or third hr after d-amphetamine injection. Metoclopramide alone tended to reduce behavior. The results suggest that metoclopramide is qualitatively similar to sulpiride in its interaction with d-amphetamine, and that metoclopramide's mechanism of action is not a simple dopaminergic antagonism. Clinicians are advised that metoclopramide, which is presently extensively for gastrointestinal and other disorders, may interact adversely with drugs that affect dopaminergic function. |
Databáze: |
MEDLINE |
Externí odkaz: |
|